# SudoScan as a Biomarker of Parkinson's Disease

> **NCT02767037** · NA · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 150 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DEVICE:** Sudoscan and clinical assessment
- **GENETIC:** Skin biopsy

## Key facts

- **NCT ID:** NCT02767037
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2018-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02767037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02767037, "SudoScan as a Biomarker of Parkinson's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02767037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*